Relay Therapeutics, Inc. (RLAY) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $54.27M | -42.0% |
| 2024 | $93.50M | +1.7% |
| 2023 | $91.98M | -38.5% |
| 2022 | $149.55M | +35.2% |
| 2021 | $110.64M | +202.8% |
| 2020 | $36.54M | +2.3% |
| 2019 | $35.73M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $54.27M | -42.0% |
| 2024 | $93.50M | +1.7% |
| 2023 | $91.98M | -38.5% |
| 2022 | $149.55M | +35.2% |
| 2021 | $110.64M | +202.8% |
| 2020 | $36.54M | +2.3% |
| 2019 | $35.73M | — |